Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer

NCT03466788 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT03466788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03466788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer
Lead sponsor
Centre Francois Baclesse
Phase
Not applicable
Overall status
Completed
Start date
March 29, 2018
Completion date
March 28, 2020
Enrollment
51 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, endometrial cancer, quality of life